Angiogenesis Not Yet Recruiting Phase 2 Trials for Rivoceranib (DB14765)

IndicationStatusPhase
DBCOND0036757 (Angiogenesis)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03193814Safety and Efficacy Study of Chemotherapy Plus Apatinib as Second-line Therapy in Metastatic Colorectal CancerTreatment